TLDR Oral minoxidil may help hair regrowth in female cancer survivors.
The study evaluated the effectiveness of oral minoxidil (1.25 mg daily) in treating late alopecia in 216 female cancer survivors, primarily with a history of breast cancer, who experienced incomplete hair regrowth following chemotherapy and/or endocrine therapy. After a median of 105 days, 74% of patients showed clinical improvement in hair regrowth. Trichoscopy assessments indicated a significant increase in hair density in both frontal and occipital areas, although hair thickness did not significantly change. The treatment was well tolerated, with no patients discontinuing due to adverse effects. The study suggests oral minoxidil may be beneficial for late alopecia in this population, but further prospective, controlled studies are needed to confirm these findings.
January 2023 in “Journal der Deutschen Dermatologischen Gesellschaft” Early diagnosis and personalized treatment are crucial for managing hair loss in children.
1 citations,
October 2022 in “PubMed” Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.
1 citations,
August 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
1 citations,
August 2021 in “Cosmoderma” Low-dose oral minoxidil is effective and well-tolerated for treating hair loss.
1 citations,
October 2020 in “Journal of Cosmetic Dermatology” Using minoxidil and tofacitinib together can effectively treat severe hair loss.
April 2019 in “Zagazig university medical journal” 1 citations,
February 2019 in “PubMed” Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.
14 citations,
January 2015 in “Skin appendage disorders” Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.
127 citations,
July 1996 in “Journal of The American Academy of Dermatology” Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.